Skip to main content
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 18, Number 9, 2011

Articles

Purine Salvage Pathway in Mycobacterium tuberculosis
pp. 1258-1275(18)
Authors: G. Ducati, R.; Breda, A.; A. Basso, L.; S. Santos, D.

Favourites:
ADD
Favourites:
ADD

Pyrimidine Salvage Pathway in Mycobacterium tuberculosis
pp. 1286-1298(13)
Authors: D. Villela, A.; A. Sanchez-Quitian, Z.; G. Ducati, R.; S. Santos, D.; A. Basso, L.

Favourites:
ADD

Shikimate Kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: Kinetics and Structural Dynamics of a Potential Molecular Target for Drug Development
pp. 1299-1310(12)
Authors: M. Saidemberg, D.; W. Passarelli, A.; V. Rodrigues, A.; A. Basso, L.; S. Santos, D.; S. Palma, M.

Favourites:
ADD
Favourites:
ADD

The β-Ketoacyl-ACP Synthase from Mycobacterium tuberculosis as Potential Drug Targets
pp. 1318-1324(7)
Authors: Singh, V.; Mani, I.; K. Chaudhary, D.; Somvanshi, P.

Favourites:
ADD
Favourites:
ADD

Bio-Inspired Algorithms Applied to Molecular Docking Simulations
pp. 1339-1352(14)
Authors: Heberle, G.; F. de Azevedo, W.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action
pp. 1380-1404(25)
Authors: K. Shin, J.; T. Malone, D.; T. Crosby, I.; Capuano, B.

Favourites:
ADD

Regulation of Gene Expression by Retinoids
pp. 1405-1412(8)
Authors: M. Amann, P.; B. Eichmuller, S.; Schmidt, J.; V. Bazhin, A.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content